SOUTH SAN FRANCISCO, Calif., and NEW HAVEN, Conn., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Simcha Therapeutics (“Simcha”), a clinical-stage ...
A review of recent literature shows bioengineering is reshaping oncology, from synthetic biology to nanomedicine, but what's ...
In 2015, Bluestone led a small clinical trial to isolate and grow Tregs from diabetes patients and then reinfuse the cells ...
The researchers argue that traditional vaccine development methods, which rely heavily on laboratory experimentation and long ...
In this tough-to-treat cancer type, more patients receiving anzu-cel saw their tumors shrink and had durable responses than what's been seen with other therapies.
Scientists at UCSF have uncovered evidence that multiple sclerosis silently damages the brain years before diagnosis. By ...
LEO Pharma A/S, a global leader in medical dermatology, is advancing the understanding of skin disease and its impact on ...
Recommendation based on TULIP-SC Phase III trial results showing first-in-class Saphnelo reduced disease activity via once-weekly subcutaneous administration AstraZeneca's Saphnelo (anifrolumab) has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback